Angel News

Angel News

Back to Homepage

10th May 2018

Synthetic antibody firm secures £1.5m investment from Mercia

An East Midlands life sciences company which develops synthetic alternatives to antibodies has closed a £1.5m Series A funding round supported by Mercia Fund Managers and a number of private investors.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage